Cite Filings / REPL
Feed Companies Filings Check
Sign in

CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
822082553
Phone
(781) 222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
Filings Insiders Search text
All 662 Financials 150 Shareholder Meetings 10 Executive Compensation 131 Insider Trading 316 Beneficial Ownership Interest 86 Business Combinations 114 Public Offerings 48 Mutual Funds and ETFs 8 Others 60
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-07-29
  3. DEF 14A Proxy Proxy Statement 2025-07-25
  4. DEF 14A Proxy Proxy Statement 2024-07-19
  5. DEF 14A Proxy Proxy Statement 2023-07-26
  6. DEF 14A Proxy Proxy Statement 2022-07-27
  7. DEF 14A Proxy Proxy Statement 2021-07-22
  8. DEF 14A Proxy Proxy Statement 2020-07-29
  9. DEF 14A Proxy Proxy Statement 2019-08-09

Page 1 of 1 · 8 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…